ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn 
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions 
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback 
Peru’s Ex-President Martín Vizcarra Sentenced to 14 Years in Prison for Corruption 
BOJ Faces Pressure for Clarity, but Neutral Rate Estimates Likely to Stay Vague 
China’s Services Sector Posts Slowest Growth in Five Months as Demand Softens 
Northwestern University to Restore Research Funding Under $75 Million Agreement with U.S. Government 
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 
Bristol Myers Faces $6.7 Billion Lawsuit After Judge Allows Key Shareholder Claims to Proceed 
Brazil’s Supreme Court Orders Jair Bolsonaro to Begin 27-Year Prison Term 
Bolsonaro Detained Over Alleged Escape Risk After Ankle Monitor Tampering 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
USPS Expands Electric Vehicle Fleet as Nationwide Transition Accelerates 
Netflix Nearing Major Deal to Acquire Warner Bros Discovery Assets 
Bolsonaro Blames Medication Mix-Up for Ankle Monitor Tampering as Detention Continues 
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
Abbott Laboratories faces a criminal investigation by the Justice Department, after its recall of formulas due to complaints of bacterial infections exacerbated a shortage that began due to pandemic-induced supply chain issues.
The Justice Department was investigating conduct at Abbott’s plant in Sturgis, Michigan,
According to an Abbott spokesman, they are fully cooperating with the Justice Department without specifying what aspect of the company is under scrutiny.
In February 2022, Abbott, the biggest US supplier of baby formula, recalled Similac and other infant formula products produced at its Michigan facility after reports of bacterial infections in babies who had consumed products made there.
The US Food and Drug Administration found "shocking" results during an inspection, such as cracks in vital equipment, inadequate hand-washing, and evidence of previous bacterial contamination.
The plant has since reopened.
